Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata is a hair loss condition that often starts before age 30 and can affect various body parts, with unpredictable hair regrowth chances.

Hair loss treated with minoxidil, finasteride, laser/light, hair transplant, and scalp prostheses; more research needed for skin of color.

Latanoprost can effectively treat eyelash hair loss, with 45% of patients showing hair regrowth and no reported side effects.

Some treatments work for common baldness, but there's less evidence for other hair loss types, and more research is needed.

Hair thickness differences help diagnose hair loss severity.

Early stage bald spots are linked to skin inflammation and damage to the upper part of the hair follicle.

Late-onset alopecia areata in Taiwanese patients is more common in women, usually starts at age 57, often involves less than 10% hair loss, and may have a minimal link to thyroid issues.

Hair loss in women can be slowed with treatment, but more research needed for better solutions.

People with alopecia areata have higher rates of mental health issues, autoimmune diseases, and infections.

Early diagnosis and combination therapy, especially with finasteride and dutasteride, are key to managing Frontal Fibrosing Alopecia effectively.

Higher social status is linked to earlier diagnosis and better treatment results for Frontal Fibrosing Alopecia in women.

The document concludes that alopecia areata is an unpredictable autoimmune hair loss condition with no cure, but various treatments exist that require personalized approaches.

Mesotherapy is more effective than topical spray for female hair loss treatment.

Male gender and family history predict alopecia areata recurrence.

Certain hair styling methods, like weaving and straightening, are a main cause of hair loss in women from Bamako.

Frontal fibrosing alopecia mostly affects postmenopausal women, with diagnosis often delayed by 3 years.

Etanercept, a psoriasis treatment, caused hair loss in a patient.

Niosomal minoxidil, when applied topically, increases hair count more than conventional minoxidil solution.

AGA causes hair loss by shrinking hair follicles due to DHT binding, and can be treated with finasteride and minoxidil.

Skin grafts on mice can cause an immune response leading to hair loss, useful for studying human hair loss conditions.

There may be a connection between Frontal Fibrosing Alopecia and Lichen Planus Pigmentosus, and more research is needed to confirm this.

The document concludes that proper diagnosis and FDA-approved treatments for different types of hair loss exist, but treatments for severe cases often fail and future improvements may focus on hair follicle stem cells.

The cause of Frontal Fibrosing Alopecia is unclear, diagnosis involves clinical evaluation and various treatments exist, but their effectiveness is uncertain.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

SACUMAN, a rare condition causing hair loss without clear signs, is often misdiagnosed and needs scalp biopsies for accurate detection.

Older age at onset of alopecia areata leads to less severe and shorter episodes, with most patients experiencing significant hair regrowth.

Three white adults had a rare scalp condition with increased fat and sometimes hair loss, suggesting it's not limited to black women and might be more widespread.

Genes linked to fibrosis are more active in people with central centrifugal cicatricial alopecia.

Korean Red Ginseng may help improve hair regrowth when used with corticosteroid injections for Alopecia Areata.

The document concludes that ongoing research using animal models is crucial for better understanding and treating Alopecia Areata.